Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.

NCT01155258 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01155258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01155258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
May 31, 2014
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung cancer, hereditary paraganglioma, male breast cancer, malignant paraganglioma, metastatic gastrointestinal carcinoid tumor, metastatic pheochromocytoma, pancreatic polypeptide tumor, recurrent breast cancer, recurrent cervical cancer, recurrent endometrial carcinoma, recurrent gastrointestinal carcinoid tumor, recurrent islet cell carcinoma, recurrent neuroendocrine carcinoma of the skin, recurrent non-small cell lung cancer, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, recurrent pheochromocytoma, recurrent prostate cancer, recurrent renal cell cancer, recurrent small cell lung cancer, recurrent uterine sarcoma, regional gastrointestinal carcinoid tumor, regional pheochromocytoma, stage iii cervical cancer, stage iii endometrial carcinoma, stage iii neuroendocrine carcinoma of the skin, stage iii ovarian epithelial cancer, stage iii ovarian germ cell tumor, stage iii prostate cancer, stage iii renal cell cancer, stage iii uterine sarcoma, stage iiia breast cancer, stage iiia non-small cell lung cancer, stage iiib breast cancer, stage iiib non-small cell lung cancer, stage iiic breast cancer, stage iv breast cancer, stage iv endometrial carcinoma, stage iv neuroendocrine carcinoma of the skin, stage iv non-small cell lung cancer, stage iv ovarian epithelial cancer, stage iv ovarian germ cell tumor, stage iv prostate cancer, stage iv renal cell cancer, stage iv uterine sarcoma, stage iva cervical cancer, stage ivb cervical cancer, thyroid gland medullary carcinoma